• PDF / 169,105 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 72 Downloads / 194 Views

DOWNLOAD

REPORT

1 S

Elevated transaminase: case report In a real-world retrospective study involving 39 patients (treated at Sun-Yat Sen University Cancer Centre in China between June 2017 and May 2019), a patient [age and sex not stated] was described, who exhibited grade 3/4 treatment-related adverse event in the form of elevated transaminase during treatment with vemurafenib and unspecified programmed cell death-1 receptor antagonist [programmed cell death-1 blockade] for advanced BRAFV600-mutant melanoma [route, dosage, duration of treatment to reaction onset and outcome not stated]. Wen X, et al. A real-world study of vemurafenib plus anti-PD-1 antibody in Chinese patients with advanced BRAF V600-mutant melanoma. Annals of Oncology 31 (Suppl. 803506003 4): S751-S752 abstr. 1114P, Sep 2020. Available from: URL: http://doi.org/10.1016/j.annonc.2020.08.1237 [abstract]

0114-9954/20/1825-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 10 Oct 2020 No. 1825

Recommend Documents

Aldesleukin/programmed-cell-death-1-receptor-antagonists

166 45 167KB

Programmed-cell-death-1-receptor-antagonists/rivoceranib

179 72 165KB

Amoxicillin/clavulanic-acid/ipilimumab/programmed-cell-death-1-receptor-antagonists

168 92 167KB

Programmed Cell Death

202 62 6MB

Programmed Cell Death: Historical Notes from Russia

257 82 199KB

Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. C

139 96 2MB

Programmed Cell Death Methods and Protocols

161 33 10MB

Plant Programmed Cell Death Methods and Protocols

176 107 4MB

B Cell Receptor Signaling

241 59 5MB

Low Oxygen Stress, Nonsymbiotic Hemoglobins, NO, and Programmed Cell Death

250 98 261KB

Effector Cell Protease Receptor-1

193 8 4MB

Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell

161 40 1MB